Colleran David

Directeur Exécutif, Conseiller Juridique Général

BoardM

US·SEC (Form 4)

Anika Therapeutics, Inc.

0

Total declarations

0

Company

€67,062

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Explore the detailed record of transactions filed by Colleran David, Directeur Exécutif, Conseiller Juridique Général. Director active across 1 companies, notably Anika Therapeutics, Inc.. Aggregated, 4 filings have been recorded. Total volume traded: €67k. The latest transaction was filed on 11 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.

Declarations4 total

Executives▲PurchaseAAnika Therapeutics, Inc.25SEC

C

Colleran DavidEVP, General Counsel, Corp Sec

€30,4921,500 shares@ €20.32820.015% mcap45.5% of flow

Common Stock

SEC:0001171843-22-003615:0·11 May 2022

Ideal exit: 5 Feb 2023 (T+270)

SEC ↗

Executives▲PurchaseAAnika Therapeutics, Inc.42SEC

C

Colleran DavidEVP, General Counsel, Corp Sec

€36,5691,500 shares@ €24.37970.018% mcap54.5% of flow

Common Stock

SEC:0001171843-22-001915:0·14 Mar 2022

Ideal exit: 9 Dec 2022 (T+270)

SEC ↗

Executives◇OptionsAAnika Therapeutics, Inc.12SEC

C

Colleran DavidEVP, General Counsel, Corp Sec

03,682 shares0

Common Stock

SEC:0001171843-22-001810:0·9 Mar 2022

SEC ↗

Executives◇OptionsAAnika Therapeutics, Inc.12SEC

C

Colleran DavidEVP, General Counsel, Corp Sec

02,500 shares0

Common Stock

SEC:0001171843-22-001664:0·4 Mar 2022

SEC ↗

4 of 4 declarations

About Colleran David

David Colleran is the EVP, General Counsel, and Corporate Secretary at Anika Therapeutics, Inc. He oversees the company's legal and regulatory affairs and ensures compliance with applicable laws. Colleran plays a key role in risk management and protecting the company's interests.